Ajanta Pharma Limited · NSE: AJANTPHARM · BSE: 532331
Ajanta Pharma
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 30 Jul 2026.
Q1 FY27 · Consolidated
Revenue
1,625.96₹ Cr
+24.8% vs year ago
Net profit
334.22₹ Cr
+30.9% vs year ago
EPS, basic
26.75₹
+30.9% vs year ago
Net margin
20.6%
+1.0 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 1,625.96 | +24.8% | 334.22 | +30.9% | 26.75 | 30 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 1,421.64 | +21.5% | 266.70 | +18.4% | 21.35 | 05 May 2026 |
| Q3 FY26Oct–Dec 2025 | 1,374.84 | +20.0% | 273.77 | +17.6% | 21.91 | 30 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 1,353.73 | +14.1% | 260.19 | +20.2% | 20.83 | 03 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 1,302.65 | +13.8% | 255.34 | +3.9% | 20.44 | 28 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 1,170.41 | +11.0% | 225.26 | +11.1% | 18.00 | 30 Apr 2025 |
| Q3 FY25Oct–Dec 2024 | 1,146.13 | +3.7% | 232.88 | +10.9% | 18.60 | 30 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 1,186.64 | +15.4% | 216.48 | +10.8% | 17.27 | 29 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 1,144.92 | +12.1% | 245.77 | +18.1% | 19.54 | 31 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 1,054.08 | +19.5% | 202.72 | +65.8% | 16.10 | 03 May 2024 |
| Q3 FY24Oct–Dec 2023 | 1,105.15 | +13.7% | 210.03 | +56.1% | 16.68 | 01 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 1,028.44 | +9.6% | 195.30 | +24.7% | 15.51 | 01 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 1,021.04 | +7.4% | 208.12 | +19.2% | 16.53 | 27 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 881.84 | +1.3% | 122.25 | −19.2% | 9.54 | 08 May 2023 |
| Q3 FY23Oct–Dec 2022 | 971.77 | +16.0% | 134.51 | −29.9% | 10.50 | 02 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 938.10 | +6.0% | 156.60 | −20.1% | 12.22 | 04 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 950.93 | +27.1% | 174.62 | +0.5% | 13.63 | 29 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 870.29 | +15.0% | 151.21 | −5.1% | 17.70 | 11 May 2022 |
| Q3 FY22Oct–Dec 2021 | 837.91 | +11.9% | 191.78 | +8.6% | 22.16 | 31 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 884.80 | +23.6% | 195.94 | +15.1% | 22.64 | 01 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 747.99 | +11.9% | 173.75 | +17.6% | 20.08 | 30 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 756.84 | +11.0% | 159.26 | +23.3% | 18.40 | 03 May 2021 |
| Q3 FY21Oct–Dec 2020 | 748.74 | +15.0% | 176.63 | +64.2% | 20.41 | 03 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 715.91 | +11.4% | 170.22 | +46.3% | 19.51 | 04 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 668.20 | +9.2% | 147.76 | +28.9% | 16.93 | 31 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 681.96 | +32.4% | 129.16 | +45.3% | 14.80 | 21 May 2020 |
| Q3 FY20Oct–Dec 2019 | 651.21 | +34.2% | 107.55 | +60.8% | 12.33 | 06 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 642.76 | +18.1% | 116.36 | −7.2% | 13.34 | 06 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 611.94 | +19.8% | 114.63 | +8.4% | 13.14 | 01 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 515.16 | — | 88.89 | — | 10.10 | 02 May 2019 |
| Q3 FY19Oct–Dec 2018 | 485.11 | — | 66.90 | — | 7.60 | 31 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 544.11 | — | 125.39 | — | 14.25 | 01 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 510.99 | — | 105.79 | — | 12.02 | 31 Jul 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 1,488.67 | +23.2% | 315.47 | +23.7% | 25.25 | 30 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 1,210.53 | +19.4% | 197.28 | +2.0% | 15.79 | 05 May 2026 |
| Q3 FY26Oct–Dec 2025 | 1,206.59 | +9.5% | 245.04 | −2.9% | 19.61 | 30 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 1,220.24 | +8.1% | 249.53 | +6.2% | 19.98 | 03 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 1,208.56 | +12.2% | 254.97 | +8.0% | 20.41 | 28 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 1,013.94 | +9.5% | 193.43 | +18.9% | 15.46 | 30 Apr 2025 |
| Q3 FY25Oct–Dec 2024 | 1,101.92 | +1.5% | 252.45 | +14.7% | 20.16 | 30 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 1,128.91 | +19.4% | 234.98 | +10.7% | 18.75 | 29 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 1,077.27 | +6.2% | 236.03 | +11.3% | 18.77 | 31 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 926.07 | +9.1% | 162.69 | +38.8% | 12.92 | 03 May 2024 |
| Q3 FY24Oct–Dec 2023 | 1,085.29 | +24.0% | 220.15 | +77.6% | 17.48 | 01 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 945.18 | +12.9% | 212.36 | +27.0% | 16.87 | 01 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 1,014.58 | +19.3% | 212.04 | +41.0% | 16.84 | 27 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 848.86 | +10.9% | 117.21 | −13.1% | 9.15 | 08 May 2023 |
| Q3 FY23Oct–Dec 2022 | 874.89 | +8.2% | 123.96 | −36.3% | 9.67 | 02 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 837.23 | +1.6% | 167.18 | −15.1% | 13.05 | 04 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 850.29 | +14.5% | 150.37 | −22.3% | 11.74 | 29 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 765.63 | +2.3% | 134.84 | −12.9% | 15.79 | 11 May 2022 |
| Q3 FY22Oct–Dec 2021 | 808.58 | +10.3% | 194.71 | +8.2% | 22.50 | 31 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 823.71 | +21.8% | 196.85 | −12.6% | 22.75 | 01 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 742.72 | +32.4% | 193.46 | +67.2% | 22.36 | 30 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 748.07 | +33.4% | 154.78 | +74.9% | 17.89 | 03 May 2021 |
| Q3 FY21Oct–Dec 2020 | 733.16 | +38.2% | 179.95 | +66.1% | 20.80 | 03 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 676.51 | +20.9% | 225.22 | +86.6% | 25.81 | 04 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 560.85 | +2.8% | 115.69 | −6.4% | 13.26 | 31 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 560.68 | +35.6% | 88.51 | +113.9% | 10.14 | 21 May 2020 |
| Q3 FY20Oct–Dec 2019 | 530.55 | +17.4% | 108.32 | +13.5% | 12.41 | 06 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 559.45 | +20.2% | 120.70 | +15.9% | 13.83 | 06 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 545.74 | +23.5% | 123.60 | −18.0% | 14.17 | 01 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 413.53 | — | 41.37 | — | 4.70 | 02 May 2019 |
| Q3 FY19Oct–Dec 2018 | 451.85 | — | 95.47 | — | 10.85 | 31 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 465.29 | — | 104.10 | — | 11.83 | 01 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 441.95 | — | 150.82 | — | 17.14 | 31 Jul 2018 |
66 filings on record for this company.